COVID-19 vaccines and therapeutic products
COVID-19 vaccines and therapeutic products
Several traditional and novel drugs from the CIGB make up Cuban COVID-19 treatment protocols, as well as a vaccine and a vaccine candidate currently in advanced clinical trials. Cuba deploys mass vaccination of its population in 2021.
Vaccine and vaccine candidates
Therapeutic products
Immunomodulatory peptide: a new therapeutic alternative to control hyperinflammation, regulate the immune response and reduce the risk of mortality...
Recombinant human interferon alfa 2b for nasal application for the prophylaxis of SARS-CoV-2 virus infection.
Important modifier of the biological response. It is antiviral, antiproliferative and immunomodulatory.
Pharmaceutical combination in synergistic ratio of recombinant human interferon alpha 2b and recombinant human interferon gamma for the treatment...
Hebertrans® Drug containing transfer factor. Hebertrans® is useful for the treatment of patients with cellular immunodeficiency, herpes zoster, herpes...
